Mindfulness Prevents Depression and Psychopathology in Elderly People with Mild to Moderate Alzheimer's Disease: A Randomized Clinical Trial

被引:4
|
作者
Quintana-Hernandez, Domingo J. [1 ]
Rojas-Hernandez, Jaime [2 ]
Santana-Del Pino, Angelo [3 ]
Cespedes Suarez, Carmen [1 ]
Pellejero Silva, Monica [4 ]
Teresa Miro-Barrachina, Maria [5 ]
Ibanez Fernandez, Ignacio [5 ]
Estupinan Lopez, Jose Antonio [2 ]
Borkel, Lucas F. [6 ]
机构
[1] Atlantico Medio Univ, Dept Psychol, Tafira Baja, Spain
[2] Assoc Canaria Desarrollo Salud Traves Atenc, Las Palmas Gran Canaria, Spain
[3] Las Palmas de Gran Canaria Univ, Dept Math, Las Palmas Gran Canaria, Spain
[4] Atlantico Medio Univ, Dept Commun, Tafira Baja, Spain
[5] La Laguna Univ, Dept Clin Psychol Psychobiol & Methodol, San Cristobal la Laguna, Spain
[6] Assoc Cient Psicodel, Las Palmas Gran Canaria, Spain
关键词
Alzheimer's disease; cognitive stimulation; mindfulness; randomized clinical trial; relaxation; EPIDEMIOLOGY; DEMENTIA;
D O I
10.3233/JAD-220889
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: This longitudinal study addressed whether mindfulness practice prevents psychological and behavioral symptoms, especially mood disorders, in Alzheimer's disease (AD). Objective: To assess the incidence of depression in the course of AD and to determine which non-pharmacological treatment (NPT) is most effective in preventing psychopathological symptoms. Methods: We conducted a longitudinal, non-inferiority and equivalence randomized clinical trial, repeated-measures design, with a control group and three experimental treatments: mindfulness, cognitive stimulation, and relaxation. Each experimental group performed three weekly sessions for two years. The pharmacological treatment of all participants was donepezil (10 mg). Participants were patients with probable AD without diagnosed depression from the public neurology services of the Canary Health Service, Spain. Psychological evaluation was performed using the Geriatric Depression Scale (GDS), Hamilton Depression Rating Scale (HDRS), and Neuropsychiatric Inventory (NPI-Q). The statistical analysis included only patients who attended at least 75% of the sessions. A nonparametric, repeated-measures analysis was performed with Kruskal-Wallis H test and between-group differences with Mann-Whitney U test with Bonferroni correction (p < 0.008). Effect size was calculated with partial eta-squared. Results: The results showed significant differences with large effect sizes (eta(2)(p)>0.14) between mindfulness and the rest of the experimental groups as well as the control in the GDS, HDRS, and NPI-Q scales. Conclusion: Compared to the other experimental groups, only mindfulness prevented the onset of depression and other psychopathologies in early-stage AD. Based on its effectiveness in maintaining cognitive functions and preventing psychopathology, we recommend mindfulness as the first-choice NPT for mild to moderate AD.
引用
收藏
页码:471 / 481
页数:11
相关论文
共 50 条
  • [31] Memantine Versus Donepezil in Mild to Moderate Alzheimer's Disease. A Randomized Trial with Magnetic Resonance Spectroscopy
    Modrego, Pedro J.
    Fayed, Nicolas
    Errea, Jose M.
    Rios, Consuelo
    Pina, Miguel A.
    Sarasa, Manuel
    NEUROLOGY, 2009, 72 (11) : A298 - A298
  • [32] 'Mindfulness in sounds': a randomized controlled feasibility trial of sound meditation for anxiety and depression for people with Parkinson's Disease
    Kwok, Jojo Yan Yan
    Wong, Janet Yuen Ha
    Fong, Daniel Yee Tak
    Kwan, Jackie Cheuk Yin
    Yu, Shirley Pang Yin
    Auyeung, Man
    INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 2021, 28 (SUPPL 1) : S99 - S100
  • [33] Acupuncture for early Parkinson's disease with mild to moderate depression: a randomized controlled trial protocol with functional MRI
    Xiao, Hongli
    Ren, Yashuo
    Yang, Haosen
    Wang, Zixi
    Li, Zhuohao
    Song, Yuguo
    Yuan, Xiaojia
    Liu, Xiaopeng
    Chen, Peng
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [34] Effect of Rotigotine vs Placebo on Cognitive Functions Among Patients With Mild to Moderate Alzheimer Disease A Randomized Clinical Trial
    Koch, Giacomo
    Motta, Caterina
    Bonni, Sonia
    Pellicciari, Maria Concetta
    Picazio, Silvia
    Casula, Elias Paolo
    Maiella, Michele
    Di Lorenzo, Francesco
    Ponzo, Viviana
    Ferrari, Clarissa
    Scaricamazza, Eugenia
    Caltagirone, Carlo
    Martorana, Alessandro
    JAMA NETWORK OPEN, 2020, 3 (07)
  • [35] Clinical efficacy of acupuncture combined with Western medicine in the treatment of mild to moderate Alzheimer disease: A protocol of a randomized controlled trial
    Zhou, Kangmei
    He, Jierong
    Quan, Lin
    Guo, Rong
    MEDICINE, 2022, 101 (39) : E30705
  • [36] The effects of auriculotherapy on depression among elderly people: A randomized controlled clinical trial
    Josheghani, Mohammad Abbasian
    Tagharrobi, Zahra
    Sharifi, Khadijeh
    Sooki, Zahra
    Joshaghani, Fatemeh Zare
    Zare, Mohammad
    COMPLEMENTARY THERAPIES IN MEDICINE, 2024, 83
  • [37] MINDFULNESS BASED STIMULATION FOR ELDERLY PEOPLE WITH ALZHEIMER'S DISEASE OR OTHER TYPES OF DEMENTIA
    Quintana Hernandez, Domingo Jesus
    Miro Barrachina, Maria Teresa
    PAPELES DEL PSICOLOGO, 2015, 36 (03): : 207 - 215
  • [38] Correction: Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial
    Bruno Dubois
    Jesús López‑Arrieta
    Stanley Lipschitz
    Triantafyllos Doskas
    Luiza Spiru
    Svitlana Moroz
    Olena Venger
    Patrick Vermersch
    Alain Moussy
    Colin D. Mansfield
    Olivier Hermine
    Magda Tsolaki
    Alzheimer's Research & Therapy, 15
  • [39] A Placebo-Controlled, Parallel-Group, Randomized Clinical Trial of AC-1204 in Mild-to-Moderate Alzheimer's Disease
    Henderson, Samuel T.
    Morimoto, Bruce H.
    Cummings, Jeffrey L.
    Farlow, Martin R.
    Walker, Judith
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 75 (02) : 547 - 557
  • [40] Psychometric Properties of the Dependence Scale in Large Randomized Clinical Trials of Patients With Mild and Moderate Alzheimer's Disease
    Wyrwich, Kathleen W.
    Auguste, Priscilla
    Buchanan, Jacqui
    Rudell, Katja
    Lacey, Loretto
    Leibman, Christopher
    Symonds, Tara
    Brashear, H. Robert
    AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2014, 29 (07): : 620 - 629